Posted on:
Dec 12, 2013 10:28AM
- edited
Oct 5, 2014 02:45PM
by
moderators
M
Philadelphia
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Posted on:
Dec 12, 2013 10:28AM
- edited
Oct 5, 2014 02:45PM
by
moderators
moderators
wrote:
Please go here to read about and listen to all our Podcasts! We will also be posting podcasts below as they air.
Note: Podcasts will be available in transcript form about 24 - 48 hours after the Podcasts have aired.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Dec 16, 2021 12:32PM
moderators
wrote:
Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease
December 13, 2021
Dr. Jeremy Braybrooke, is a consultant medical oncologist and clinical lead for oncology at University Hospitals Bristol, as well as a senior clinical research fellow at the University of Oxford. Rosie Bradley is a medical statistician in the Clinical Trial Service Unit at the University of Oxford.
At the 2021 San Antonio Breast Cancer Symposium, Rosie presented the results of their meta-analysis of four studies looking at effectiveness of aromatase inhibitors compared to tamoxifen in pre-menopausal women diagnosed with early-stage, hormone receptor-positive disease.
Listen to the episode to hear them explain:
- the results of the study, showing that an aromatase inhibitor and ovarian suppression reduced recurrence risk more than tamoxifen, but didn't lead to better overall survival
- the side effects of aromatase inhibitors and tamoxifen
- how Dr. Braybrooke is advising his pre-menopausal patients diagnosed with early-stage, hormone receptor-positive disease
Running time: 14:19
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Dec 22, 2021 12:32PM
moderators
wrote:
Top Research Presented at the 2021 San Antonio Breast Cancer Symposium
December 21, 2021
Dr. Sara Tolaney is chief of the Division of Breast Oncology and associate director of the Susan F. Smith Center for Women's Cancers at the Dana-Farber Cancer Institute, as well as associate professor of medicine at Harvard Medical School.
The 2021 San Antonio Breast Cancer Symposium featured four days of presentations on the latest research on breast cancer. Dr. Tolaney joined us to discuss the research that is most immediately applicable to people who've been diagnosed with the disease.
Listen to the episode to hear Dr. Tolaney explain:
- results of an early study looking at how effective the experimental medicine datopotamab deruxtecan was in treating metastatic, triple-negative breast cancer
- a study comparing Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) to Kadcyla (chemical name: T-DM1 or ad-trastuzumab emtansine) for metastatic, HER2-positive breast cancer that had spread to the brain
- the studies that she thinks are practice-changing
Running time: 10:00
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
May 10, 2022 04:36PM
moderators
wrote:
Adolescent and Young Adult Breast Cancer
March 28, 2022
Rebecca Johnson, MD, discusses issues that are more challenging for younger women with breast cancer, reconstruction considerations for young women, and her advice for a newly diagnosed adolescent or young woman.
Listen to the episode to hear Dr. Johnson discuss:
* why the number of younger women diagnosed with breast cancer is going up, as well as the size of the increase
* issues that are more challenging for younger women with breast cancer reconstruction
* options for very young women
* her advice for a newly diagnosed adolescent or young woman
Running time: 52:45
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
May 10, 2022 04:37PM
moderators
wrote:
Dating and Breast Cancer
April 29. 2022
In this episode, four different people explain their diagnoses and how they approached dating after breast cancer.
Running time: 47:03
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
May 31, 2022 05:21PM
moderators
wrote:
Just Ask: Increasing Diversity in Clinical Trials
May 27, 2022
Dr. Nadine Barrett discusses why diversity in clinical trials is so important and how the Just Ask program helps address that lack of diversity.
Listen to the episode to hear Dr. Barrett talk about:
*why diversity in in clinical trials is so important
*what the Just Ask program is and how it works
*reactions to the program
*her recommendations for people who want to be part of a clinical trial
Running time: 28:30
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Jun 30, 2022 09:21AM
moderators
wrote:
Genetic and Genomic Tests: What's the Difference?
Brian Wojciechowski, MD, explains the differences between genetic testing and genomic testing. If you've been diagnosed with early-stage breast cancer, your doctor may have talked to you about genomic testing. You also may have heard about genetic testing. The names sound similar, but the tests are very different.
Listen to the podcast to hear Dr. Wojciechowski explain:
- how the tests are used and how they're done
- for whom the tests are recommended
- how the tests are different
- how he talks to his patients about the tests
Running time: 15:16
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Jun 30, 2022 09:21AM
moderators
wrote:
Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?
If you're immunocompromised, are you worried that other people's eagerness to get back to pre-COVID-19 "normal" will make you sick?
If you're being treated for breast cancer, you may be considered immunocompromised, meaning your immune system isn't functioning at its full capacity. As mask mandates are being dropped and other COVID-19 restrictions are loosening, many immunocompromised people feel left behind and are worried that other people's eagerness to get back to quote "normal" may make them sick.
Listen to the episode to hear Dr. Wojciechowski explain:
- vaccine effectiveness in immunocompromised people
- his mask recommendations
- how immunocompromised people can continue to protect themselves
- how he's talking to his patients about this issue
Running time: 16:30
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Jul 22, 2022 02:53PM
moderators
wrote:
Enhertu for HER2-Low Breast Cancer
Jul 8, 2022
Brian Wojciechowski, MD, explains what HER2-low breast is and the exciting results showing that Enhertu can help treat it.
At the recent 2022 American Society of Clinical Oncology Annual Meeting, researchers presented results showing Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki), which is a type of medicine doctors call an antibody-drug conjugate, improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer.
Listen to the podcast to hear Dr. Wojciechowski explain:
- what HER2-low breast cancer is
- how Enhertu works
- how the results of the DESTINY-Breast-04 study will change practice
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Jul 27, 2022 03:58PM
moderators
wrote:
Fezolinetant: A Non-Hormonal Treatment for Hot Flashes
July 22, 2022
Genevieve Neal-Perry, MD, PhD, discusses her research on fezolinetant as a treatment for hot flashes.
If you've been diagnosed with breast cancer before menopause, some of your treatments, including chemotherapy and hormonal therapy, can bring on menopause earlier and more abruptly than expected, causing hot flashes and night sweats. For some women, these symptoms can be severe and dramatically affect their quality of life.
In search of relief, some women consider hormone replacement therapy (HRT). But because HRT contains hormones — estrogen or a combination of estrogen and progesterone — which can make breast cells grow, it is not recommended for women who have been diagnosed with breast cancer.
Listen to the podcast to hear Dr. Neal-Perry explain:
- how fezolinetant works to ease hot flashes
- fezolinetant side effects
- why the results of her work on the SKYLIGHT 2 study are so exciting for women with a history of breast cancer
Listen now or read the transcript.
M
moderators
Joined:
Sep 2007
Posts:
25,640
Latest activity:
Mar 23, 2023
Aug 13, 2022 02:46PM
moderators
wrote:
How Therapy Can Help People Affected by Breast Cancer
Aug 5, 2022
Stephanie Ross, PhD, talks about how therapy can help people diagnosed with breast cancer and their caregivers, as well as how to find a therapist.
Being diagnosed with breast cancer can be scary, upsetting, and traumatic for the person diagnosed, as well as their family members. Many people could benefit from counseling and therapy, but don't know what services are available or how to find them.
Listen to the episode to hear Dr. Ross explain:
- how therapy or counseling can help people diagnosed with breast cancer
- how to find a therapist that's right for you
- why there is still a lot of stigma and embarrassment attached to therapy
- how to start the process, if you think therapy would benefit you
Listen now or read the transcript.
